AI Assistant
Blog
Pricing
Log In
Sign Up
A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
